{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:48:33Z","timestamp":1747172913662,"version":"3.40.5"},"reference-count":38,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) is a standard therapy for non\u2013muscle-invasive bladder cancer used in urology clinics and inpatient settings. We present a review of infection risks to patients receiving intravesical BCG, healthcare personnel who prepare and administer BCG, and other patients treated in facilities where BCG is prepared and administered. Knowledge of these risks and relevant regulations informs appropriate infection prevention measures.<\/jats:p>","DOI":"10.1017\/ice.2023.259","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T10:09:19Z","timestamp":1702289359000},"page":"520-525","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":0,"title":["Bacille Calmette-Gu\u00e9rin preparation and intravesical administration to patients with bladder cancer: Risks to healthcare personnel and patients, and mitigation strategies"],"prefix":"10.1017","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5503-2523","authenticated-orcid":false,"given":"Ashley H.","family":"Marx","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6132-4450","authenticated-orcid":false,"given":"Diana N.","family":"Nowicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4380-8435","authenticated-orcid":false,"given":"Rebecca B.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine M.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Sickbert-Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1726-4435","authenticated-orcid":false,"given":"David J.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"S0899823X23002593_ref17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00000637-199603000-00018","article-title":"Bacille Calmette-Gu\u00e9rin (BCG)-itis of the hand: a potential hazard for health workers","volume":"36","author":"Atiyeh","year":"1996","journal-title":"Ann Plast Surg"},{"key":"S0899823X23002593_ref31","doi-asserted-by":"crossref","first-page":"23247096211066287","DOI":"10.1177\/23247096211066287","article-title":"Mycobacterium bovis Bacillus Calmette-Gu\u00e9rin Cross-Contamination in the operating room: a case report","volume":"9","author":"Aqua","year":"2021","journal-title":"J Investig Med High Impact Case Rep"},{"key":"S0899823X23002593_ref10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MD.0000000000000119","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature","volume":"93","author":"As\u00edn","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"S0899823X23002593_ref35","unstructured":"35. American Urological Association and Society of Urologic Nurses and Associates (SUNA). Intravesical Administration of Therapeutic Medication for the Treatment of Bladder Cancer. American Urological Association website. https:\/\/www.auanet.org\/about-us\/policy-and-position-statements\/intravesical-administration-of-therapeutic-medication. Published June 2020. Accessed June 13, 2023."},{"key":"S0899823X23002593_ref21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1086\/313652","article-title":"Nosocomial transmission of Mycobacterium bovis Bacille Calmette-Guerin to children receiving cancer therapy and to their health care providers","volume":"30","author":"Waecker","year":"2000","journal-title":"Clin Infect Dis"},{"key":"S0899823X23002593_ref37","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1177\/0897190019854962","article-title":"Gene-replacement therapy: a primer for the health-system pharmacist","volume":"33","author":"Petrich","year":"2020","journal-title":"J Pharm Pract"},{"key":"S0899823X23002593_ref14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s42155-018-0036-y","article-title":"Mycotic aortic aneurysms postintravesical BCG treatment for early-stage bladder carcinoma","volume":"1","author":"Wadhwani","year":"2018","journal-title":"CVIR Endovasc"},{"key":"S0899823X23002593_ref4","unstructured":"4. NCCN clinical practice guidelines in oncology (NCCN guidelines) bladder cancer, version 2023 March. National Comprehensive Cancer Network website. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/bladder.pdf. Accessed June 9, 2023."},{"key":"S0899823X23002593_ref2","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non\u2013muscle-invasive bladder cancer: American Urological Association\/Society of Urologic Oncology guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"key":"S0899823X23002593_ref8","unstructured":"8. Merck press release, March 13, 2019. Merck website. https:\/\/www.merck.com\/news\/merck-remains-committed-to-producing-tice-bcg-for-the-treatment-of-certain-forms-of-bladder-cancer\/. Accessed March 13, 2023."},{"key":"S0899823X23002593_ref3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non\u2013muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"S0899823X23002593_ref25","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/clinids\/14.3.662","article-title":"Mycobacterial brain abscess possibly due to Bacille Calmette-Guerin in an immunocompromised child","volume":"14","author":"Coppes","year":"1992","journal-title":"Clin Infect Dis"},{"key":"S0899823X23002593_ref12","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/ccr3.1129","article-title":"Systemic BCG-osis following intravesical BCG instillation for bladder carcinoma","volume":"5","author":"Liaw","year":"2017","journal-title":"Clin Case Rep"},{"key":"S0899823X23002593_ref6","unstructured":"6. Drug shortages, BCG live intravesical. American Society of Health-System Pharmacists website. https:\/\/www.ashp.org\/drug-shortages\/current-shortages\/drug-shortage-detail.aspx?id=519. Updated April 18, 2023. Accessed June 9, 2023."},{"volume-title":"Biosafety in Microbiological and Biomedical Laboratories, Sixth Edition","year":"2020","key":"S0899823X23002593_ref20"},{"key":"S0899823X23002593_ref29","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/cid\/cix496","article-title":"Healthcare-associated Mycobacterium bovis\u2014Bacille Calmette-Gu\u00e9rin (BCG) infection in cancer patients without prior BCG instillation","volume":"65","author":"Meije","year":"2017","journal-title":"Clin Infect Dis"},{"key":"S0899823X23002593_ref33","unstructured":"33. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2016. Centers for Disease Control and Prevention website. https:\/\/www.cdc.gov\/niosh\/docs\/2016-161\/default.html. Accessed November 17, 2023."},{"key":"S0899823X23002593_ref7","unstructured":"7. Swanson, S , Sellinger, SB , Maddox-Smith, A , Harris, RG , Cookson, MS. BCG shortage info, September 2020 Member Communication and Recommendations. American Urological Association website. https:\/\/www.auanet.org\/about-us\/bcg-shortage-info. Published September 4, 2020. Accessed November 22, 2023."},{"key":"S0899823X23002593_ref24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3201\/eid2503.180686","article-title":"Bacillus Calmette-Gu\u00e9rin cases reported to the National Tuberculosis Surveillance System, United States, 2004\u20132015","volume":"25","author":"Wansaula","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"S0899823X23002593_ref5","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"S0899823X23002593_ref30","doi-asserted-by":"crossref","first-page":"bcr2018224462","DOI":"10.1136\/bcr-2018-224462","article-title":"Mycobacterium bovis BCG spinal osteomyelitis in a patient with bladder cancer without a history of BCG instillation","volume":"2018","author":"Gupte","year":"2018","journal-title":"BMJ Case Rep"},{"key":"S0899823X23002593_ref16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/344908","article-title":"Spectrum of Bacille Calmette-Gu\u00e9rin (BCG) infection after intravesical BCG immunotherapy","volume":"36","author":"Gonzalez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"S0899823X23002593_ref13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1155\/2011\/869286","article-title":"Mycobacterial brain tuberculomas due to Bacille Calmette-Gu\u00e9rin intravesical chemotherapy for bladder cancer: a case report and literature review","volume":"22","author":"Golub","year":"2011","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"S0899823X23002593_ref32","unstructured":"32. TICE BCG. Package insert. Merck & Co., Inc.; 2021\u20132022."},{"key":"S0899823X23002593_ref28","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1086\/379034","article-title":"Nosocomial Mycobacterium bovis\u2014Bacille Calmette-Gu\u00e9rin infections due to contamination of chemotherapeutics: case finding and route of transmission","volume":"188","author":"Vos","year":"2003","journal-title":"J Infect Dis"},{"key":"S0899823X23002593_ref9","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1086\/314064","article-title":"Efficacy and safety of Bacilli Calmette-Gu\u00e9rin immunotherapy in superficial bladder cancer","volume":"3","author":"Lamm","year":"2000","journal-title":"Clin Infect Dis"},{"key":"S0899823X23002593_ref23","unstructured":"23. 2020 Report of verified case of tuberculosis (RVCT) Instruction manual. Centers for Disease Control and Prevention website. https:\/\/www.cdc.gov\/tb\/programs\/rvct\/default.htm. Published August 2021. Accessed June 5, 2023."},{"year":"2020","key":"S0899823X23002593_ref36"},{"key":"S0899823X23002593_ref11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12879-018-3205-7","article-title":"Bacille Calmette-Gu\u00e9rin (BCG) spondylitis with adjacent mycotic aortic aneurysm after intravesical BCG therapy: a case report and literature review","volume":"18","author":"Kusakabe","year":"2018","journal-title":"BMC Infect Dis"},{"key":"S0899823X23002593_ref26","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1542\/peds.93.5.835","article-title":"Mycobacterium bovis spinal epidural abscess in a 6-year-old boy with leukemia","volume":"93","author":"Shope","year":"1994","journal-title":"Pediatrics"},{"key":"S0899823X23002593_ref15","first-page":"94","article-title":"Mycotic arterial aneurysm secondary to BCG intravesical instillation: a review","volume":"47","author":"Palmier","year":"2022","journal-title":"J Med Vasc"},{"key":"S0899823X23002593_ref34","first-page":"9687","article-title":"Is BCG a hazardous drug? Ask NIOSH, OSHA, and the USP","volume":"26","author":"Gomella","year":"2019","journal-title":"Can J Urol"},{"key":"S0899823X23002593_ref1","unstructured":"1. SEER*Explorer: an interactive website for SEER cancer statistics. Surveillance Research Program, National Cancer Institute. https:\/\/seer.cancer.gov\/statistics-network\/explorer\/. Updated April 19, 2023. Accessed June 5, 2023."},{"key":"S0899823X23002593_ref19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhsa.2012.11.011","article-title":"Acute mycobacterial flexor tenosynovitis following accidental Bacillus Calmette-Gu\u00e9rin inoculation in a healthcare worker: case report","volume":"38","author":"Mundinger","year":"2013","journal-title":"J Hand Surg Am"},{"key":"S0899823X23002593_ref22","unstructured":"22. CDC Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention. Menu of suggested provisions for state tuberculosis prevention and control laws. Centers for Disease Control and Prevention website. https:\/\/www.cdc.gov\/tb\/programs\/laws\/menu\/caseid.htm. Reviewed September 1, 2012. Accessed June 7, 2023."},{"key":"S0899823X23002593_ref27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1056\/NEJM199508313330905","article-title":"Brief report: meningitis due to iatrogenic BCG infection in two immunocompromised children","volume":"333","author":"Stone","year":"1995","journal-title":"N Engl J Med"},{"key":"S0899823X23002593_ref38","first-page":"12","article-title":"Safe handling of biosafety drugs and live virus vaccines","volume":"20","author":"Penzien","year":"2023","journal-title":"Pharm Purch Prod Mag"},{"key":"S0899823X23002593_ref18","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.jhsa.2008.05.019","article-title":"Chronic Mycobacterium infection of first dorsal web space after accidental Bacilli Calmette-Gu\u00e9rin injection in a health worker: case report","volume":"33A","author":"Vigler","year":"2008","journal-title":"J Hand Surg Am"}],"container-title":["Infection Control &amp; Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0899823X23002593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T18:51:10Z","timestamp":1730832670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0899823X23002593\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0899823X23002593"],"URL":"https:\/\/doi.org\/10.1017\/ice.2023.259","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"type":"print","value":"0899-823X"},{"type":"electronic","value":"1559-6834"}],"subject":[],"published":{"date-parts":[[2023,12,11]]},"assertion":[{"value":"\u00a9 The Author(s), 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}